Molecular Docking Study For Adenosine Monophosphate-Activated Protein Kinase Agonist From Syzygium Cumini For Treatment Of Diabetes Mellitus-Type 2. Journal of Pharmaceutical Negative Results, [S. l.], p. 1078–1085, 2023. DOI: 10.47750/pnr.2023.14.S02.132. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/6925.. Acesso em: 6 jun. 2026.